EyePoint, Inc.
EYPT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001314102
In the last 90 days, EyePoint, Inc. insiders filed 1 open-market purchase and 1 sale; 188 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $52.3K in total
- 1
- Insider sellsLast 90 days, $73.2K in total
- 1
- 13F holdersQ2 2026, +1 vs. previous quarter
- 188
- 13F valueReported value at the end of Q2 2026
- $1.33B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding EYPT, Q2 2026
No superinvestor reported holding EYPT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by EyePoint, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)4:08 PM ET | Aug 18 | Same day | Zaderej Karen L.Director | PPurchase | +10.6K | $4.93 | +$52.3K | +27.5%49.1K after | |
| Jul 2, 2026 (view filing)4:03 PM ET | Jun 30 | 2 days | Ribeiro RamiroChief Medical Officer | SSale | −4.88K | $15.01 | −$73.2K | −100.0%0 after | 2 lots10b5-1 |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $15.00 | −$36.6K | −100.0%0 after | 10b5-1 |
| Mar 16, 2026 (view filing) | Mar 16 | Same day | Duker Jay S.President and CEO | PPurchase | +1.50K | $13.15 | +$19.7K | +1.5%100.7K after | |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $17.87 | −$43.6K | −100.0%0 after | 10b5-1 |
| Feb 18, 2026 (view filing) | Feb 17 | 1 day | Ribeiro RamiroChief Medical Officer | SSale | −2.44K | $15.00 | −$36.6K | −100.0%0 after | 10b5-1 |
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Ribeiro RamiroChief Medical Officer | SSale | −42.5K | $17.10 | −$727.5K | −100.0%0 after | 10b5-1 |
| Dec 8, 2025 (view filing)4:03 PM ET | Dec 4 | 4 days | Cormorant Asset Management, LP and 2 othersOther: Former 10% Owner | SSale | −60.0K | $15.70 | −$942.2K | −0.7%8.27M after | |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Lurker NancyDirector | SSale | −9.30K | $15.11 | −$140.5K | −4.3%206.5K after | 10b5-1 |
| Dec 1, 2025 (view filing) | Nov 26-28 | 5 days | Lurker NancyDirector | SSale | −700 | $14.95 | −$10.5K | −0.3%215.8K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in EyePoint, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8,296,375 | $118.6M | 2.49% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,463,197 | $106.7M | 0.00% | +285,860+4.0% | Added |
| Cormorant Asset Management, LP | 7,000,000 | $100.1M | 5.13% | −1,265,000−15.3% | Reduced |
| Federated Hermes, Inc. | 5,681,052 | $81.2M | 0.12% | +11,463+0.2% | Added |
| Adage Capital Partners GP, L.L.C. | 4,827,792 | $69.0M | 0.10% | +1,527,792+46.3% | Added |
| Franklin Resources Inc | 4,807,078 | $68.7M | 0.01% | −241,520−4.8% | Reduced |
| Commodore Capital LP | 4,600,000 | $65.8M | 3.92% | +1,775,000+62.8% | Added |
| Jupiter Topco LLC | 3,770,381 | $53.9M | 0.02% | +3,770,381 | New |
| Vanguard Capital Management LLC | 3,630,252 | $51.9M | 0.00% | +70,683+2.0% | Added |
| Paradigm Biocapital Advisors LP | 2,890,397 | $41.3M | 0.77% | −252,040−8.0% | Reduced |